Post Fri Dec 16, 2022 7:36 pm

2022-Teh et al-Blood Adv

"Venetoclax treatment in cancer patients has limited impact on circulating T and NK cells"
Charis E Teh, Hongke Peng, Mengxiao Luo, Tania Tan, Marie Trussart, Lauren J Howson, Chong Chyn Chua, Christine Muttiah, Fiona C Brown, Matthew E Ritchie, Andrew H Wei, Andrew W Roberts, Vanessa L Bryant, Mary Ann Anderson, Geoffrey J Lindeman, David Ching Siang Huang, Rachel Thijssen, Daniel H D Gray
Blood Adv. 2022
https://doi.org/10.1182/bloodadvances.2022008221

- "Agreement to Share Publication-Related Data and Data Sharing Statement:
FLOW AND MASS CYTOMETRY DATASETS
a) AML (Flow repository ID FR-FCM-Z57G) Pre-publication reviewer access: [Mass cytometry, according to reviewer FR link]
https://flowrepository.org/id/RvFrmmNI3 ... 8IiTO5ui4b.

b) CLL (Flow repository FR-FCM-Z586) Pre-publication reviewer access: [Flow cytometry, according to reviewer FR link]
https://flowrepository.org/id/RvFroBVEZ ... k99UQdU1og.
- [note: Fig 1 of the paper implies that CLL samples were run by CyTOF too, so FR description may be incorrect)

c) Breast cancer (Flow repository FR-FCM-Z57H) Pre-publication reviewer access: [Flow cytometry, according to reviewer FR link]
https://flowrepository.org/id/RvFrbVwfd ... z8BHX6shDT

CITE-seq DATASET European Genome-Phenome Archive (EGAS00001006241) and scripts available at
https://github.com/HongkePn/Circulating_T_NK_under_VEN"